Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 30;14(13):4633.
doi: 10.3390/jcm14134633.

Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review

Ramona Cioboata  1   2 , Mara Amalia Balteanu  3 , Denisa Maria Mitroi  4 , Sidonia Catalina Vrabie  5 , Silviu Gabriel Vlasceanu  6   7 , Gabriela Marina Andrei  1 , Anca Lelia Riza  8   9 , Ioana Streata  8   9 , Ovidiu Mircea Zlatian  10 , Mihai Olteanu  1   2
Affiliations
Review

Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review

Ramona Cioboata et al. J Clin Med. .

Abstract

Chronic obstructive pulmonary disease (COPD) is an escalating global health burden, with a disproportionate impact on low- and middle-income countries (LMICs). Although tobacco smoking is a well-established risk factor, emerging evidence highlights the significant role of non-smoking exposure in driving the prevalence of COPD in these regions. This narrative review synthesizes current data on key non-smoking contributors, including household air pollution, ambient urban pollution, occupational exposure, early-life respiratory insults, chronic infections, and socioeconomic adversity. These risk factors are associated with distinct COPD phenotypes, often marked by increased airway inflammation, reduced emphysema, and variable airflow limitation. Such presentations are particularly common among women and younger populations in LMICs. However, diagnostic and therapeutic challenges persist, owing to limited disease awareness, under-resourced health systems, restricted access to essential medications, and financial constraints impacting adherence. Despite the proven effectiveness of non-pharmacological measures and public health interventions, their implementation remains inadequate because of infrastructural and funding limitations. Bridging these gaps requires region-specific clinical guidelines, improved diagnostic infrastructure, expanded access to affordable treatment, and culturally sensitive interventions. Future priorities include identifying robust biomarkers, refining disease definitions to accommodate non-smoking phenotypes, and advancing implementation science to improve interventions. A coordinated, context-aware global response is essential to reduce the growing burden of COPD in LMICs and to ensure equitable respiratory health outcomes.

Keywords: COPD; COPD phenotypes; LMICs; chronic obstructive pulmonary disease; low- and middle-income countries; non-smoking risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Emerging non-smoking drivers of chronic obstructive pulmonary disease (COPD) in low- and middle-income countries (LMICs).
Figure 2
Figure 2
Diagnostic challenges of chronic obstructive pulmonary disease (COPD) in low- and middle-income countries (LMICs).
Figure 3
Figure 3
Public health and policy strategies for non-smoking COPD in low- and middle-income countries (LMICs).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. 2025 GOLD Report—Global Initiative for Chronic Obstructive Lung Disease—GOLD. [(accessed on 10 February 2025)]. Available online: https://goldcopd.org/2025-gold-report/
    1. Adeloye D., Song P., Zhu Y., Campbell H., Sheikh A., Rudan I. Global, Regional, and National Prevalence of, and Risk Factors for, Chronic Obstructive Pulmonary Disease (COPD) in 2019: A Systematic Review and Modelling Analysis. Lancet Respir. Med. 2022;10:447–458. doi: 10.1016/S2213-2600(21)00511-7. - DOI - PMC - PubMed
    1. Roth G.A., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736. doi: 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
    1. Lamprecht B., McBurnie M.A., Vollmer W.M., Gudmundsson G., Welte T., Nizankowska-Mogilnicka E., Studnicka M., Bateman E., Anto J.M., Burney P., et al. COPD in Never Smokers: Results from the Population-Based Burden of Obstructive Lung Disease Study. Chest. 2011;139:752. doi: 10.1378/chest.10-1253. - DOI - PMC - PubMed
    1. FastStats—Chronic Lower Respiratory Disease. [(accessed on 28 January 2025)]; Available online: https://www.cdc.gov/nchs/fastats/copd.htm.

LinkOut - more resources